Compulsory licenses in the pharmaceutical industry: pricing and R\&D strategies

DOI10.1016/J.EJOR.2019.10.021zbMath1431.91079OpenAlexW2984457280MaRDI QIDQ2286895

Domenico De Giovanni, Archita Sarmah, Pietro De Giovanni

Publication date: 23 January 2020

Published in: European Journal of Operational Research (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.ejor.2019.10.021

zbMATH Keywords

game theoryR\&Dpricingpharmaceutical industrycompulsory license

Mathematics Subject Classification ID

Applications of game theory (91A80) Transportation, logistics and supply chain management (90B06) Production theory, theory of the firm (91B38)

Cites Work

• Licensing radical product innovations to speed up the diffusion
• Optimal return and rebate mechanism in a closed-loop supply chain game
• Firms' R\&D decisions under incomplete information
• Don't forget your supplier when remanufacturing
• Supply Chain Coordination with Revenue-Sharing Contracts: Strengths and Limitations
• Pay‐as‐you‐throw versus recycling fund system in closed‐loop supply chains with alliance recycling

This page was built for publication: Compulsory licenses in the pharmaceutical industry: pricing and R\&D strategies